Related Experiment Video
Updated: Jan 28, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.7K
GAEC1 drives colon cancer progression
Katherine Ting-Wei Lee1, Jelena Vider2, Johnny Cheuk-On Tang3
1School of Medicine, Griffith University, Gold Coast, Queensland, Australia.
Molecular Carcinogenesis
|March 3, 2019
Summary
Gene amplified in esophageal cancer 1 (GAEC1) promotes colorectal cancer growth by enhancing cell proliferation and migration. GAEC1 may regulate the Akt pathway, offering potential therapeutic targets for colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Gene amplified in esophageal cancer 1 (GAEC1) expression and copy number alterations are linked to colorectal cancer development.
- Understanding GAEC1's interactions and pathways in colorectal cancer is crucial for targeted therapy development.
Purpose of the Study:
- To identify the molecular pathways and transcriptional factors associated with GAEC1 in colorectal cancer.
- To investigate the functional role of GAEC1 overexpression in colorectal adenocarcinoma cell lines.
Main Methods:
- Transfection of colonic adenocarcinoma cell lines (SW48, SW480) with GAEC1.
- In vitro assays: proliferation, wound healing, clonogenic, apoptosis, cell cycle, and extracellular flux.
- Western blot analysis to identify GAEC1 interaction partners.
Main Results:
- GAEC1 overexpression significantly enhanced cell proliferation, migration, and clonogenic potential in colorectal cancer cells (P < 0.05).
- GAEC1 influenced mitochondrial respiration.
- Increased expression of phosphorylated protein kinase B, forkhead box O3, and matrix metallopeptidase 9 was observed.
Conclusions:
- GAEC1 plays a role in regulating gene pathways, potentially involving the Akt pathway.
- GAEC1's oncogenic functions suggest it as a potential therapeutic target for colorectal cancer.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
02:22The Colonization of Land
37.6K
Changes in the environment of the early Earth drove the evolution of organisms. As prokaryotic organisms in the oceans began to photosynthesize, they produced oxygen. Eventually, oxygen saturated the oceans and entered the air, resulting in an increase in atmospheric oxygen concentration, known as the oxygen revolution approximately 2.3 billion years ago. Therefore, organisms that could use oxygen for cellular respiration had an advantage. More than 1.5 years ago, eukaryotic cells and...
37.6K
01:37Energy to Drive Translocation
2.8K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Generally, polypeptides are unfolded by two distinct...
2.8K
02:15M-Cdk Drives Transition Into Mitosis
6.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.5K
02:07Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
01:27Drive-Reduction Theory: Push Theory of Motivation
1.2K
Clark Hull's drive-reduction theory, introduced in the 1940s and 1950s and often termed the "push theory" of motivation, provides a framework for understanding how biological and learned drives influence behavior. Hull suggested that motivation originates from the need to alleviate physiological tension caused by unmet biological necessities. The theory proposes that when a basic need, such as hunger or sleep, goes unfulfilled, it creates an internal imbalance. This imbalance, or...
1.2K